Search Press releases Keywords From To 13 Jan 2012 Otsuka Pharmaceutical and UCB focus collaboration in the area of Central Nervous System (CNS) disorders Read More 12 Jan 2012 Acquisition of own shares in the framework of employees’ long-term incentive plans Read More 9 Jan 2012 UCB announces positive top-line results from phase II open-label pilot study of Vimpat® (lacosamide) in primary generalized tonic-clonic seizures Read More 5 Jan 2012 Acquisition of own shares in the framework of employees’ long-term incentive plans Read More 29 Dec 2011 Acquisition of own shares in the framework of employees’ long-term incentive plans Read More 28 Dec 2011 Changes in UCB’s Executive Committee Read More Pagination First page Previous page Previous … Page 132 Page 133 Page 134 Page 135 Current page 136 Page 137 Page 138 Page 139 Page 140 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
